Pay attention to power law distributions
jackealtman.com
jackealtman.com
If a woman becomes pregnant while taking isotretinoin, her children WILL have birth defects. The drug also causes depression in far more cases than Roche's data suggest. The side effects are as diverse as they are serious – there exist entire forums dedicated to sufferers of this drug's permanent adverse effects.
This drug cures acne like nothing else we know. However, the same poorly understood mechanism that enables it to dry out one's skin also systematically dries one's joints of the hyaluronic acid that is so necessary for their lubrication. Since ceasing my treatment four months ago after researching causes for the cartilage damage in my right kneecap, I have been transformed from a healthy and sport-playing science undergraduate to finding even typing this message uncomfortable because of pains in my fingers. So much that I have taken for granted as a 21 year old has been taken away from me by this drug, and I'm not alone in this. I don't like to overdramatise things, and my situation should improve to some extent given time, but taking this drug is the worst decision I have ever made, and the young, impressionable people who are all-too-readily prescribed this drug must be made more aware of its risks.
Remarkably effective acne cure, yes. Wonderdrug, absolutely not. Calling it one is just disrespectful to those who have killed themselves [2] and whose lives it has damaged [3].
[1] http://en.wikipedia.org/wiki/Isotretinoin#Permanent_side_eff...
[2] http://rense.com/general32/scu.htm
[3] http://jacquelinefox.wordpress.com/2011/04/01/ibs-sufferers-...
A second, unfinished, 10 month treatment aborted after around 7 months at 0.5mg/kg/day (40mg – I'd put on 10kg of muscle). The lower dose was to reduce the almost daily nosebleeds I was experiencing on 1mg/kg/day.
A study suggests that doses as low as 0.25-0.4 mg/kg are sufficient: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2010.....
I know that when I was taking it (that was 12 years ago), the dermatologist would only prescribe it as a last resort, and, in case of a girl/woman, would always proceed with a pregnancy test first.
I personally am happy I took this drug but I can fully understand it's not your case.
Since you took the drug 12 years ago, Roche has been quite aggressive in its marketing of accutane for treating more mild acne – not necessarily as the last resort that you describe. I think it's reasonably well prescribed here in the UK, but I get the impression that it is handed out somewhat too readily in many nations, including even the USA.
Why do you think it causes depression more than the Roche data suggests? The studies about depression and suicide are similarly inconclusive: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463189/
Is the data from the Roche lawsuits available? I'd like to know what evidence is resulting in these multimillion dollar IBD/Crohn's cases.
I took two courses of Accutane after reading several research papers and population studies of side-effects. I came to the conclusion it's safe, and would be interested in seeing any data that shows otherwise.
It's anecdotally accepted that isotretinoin users have a tendency to avoid reporting depression so as to continue being prescribed the drug. It's common sense – of course there will be underreporting in cases where the reporting will prevent someone being prescribed a drug they wish to take.
After the patient and parent watch the video, I go back in the room and spend as much time as they need with whatever questions they may have - and then for girls I excuse the mom/parent to the waiting room for a careful and confidential contraception discussion!
Power laws have become a kind of popular science meme, but I don't think they are as common or powerful an explanatory tool as some would like I to believe. Or perhaps I've just been reading too much of Cosima Shalizi's blog.
it's possible that the prevalence of power laws in normal life have been overstated by people trying to drive home a point ("normal life" curves are definitely less slack than something like VC returns) but I still suspect that the majority of people underestimate them.
The blog post is essentially restating the Pareto (80/20) principle, first espoused by management consultant Joseph Juran in 1941. In the blog post he calls it a power law -- the Pareto distribution is a a power law distribution -- but it's an observation that has been made before and is known by many.
VC fund returns aren't driven by 80/20 (although they may fit that description), but by the much smaller number of outliers.
Maybe VC returns follow 80/20 and maybe they don't. It isn't exactly a public dataset that we can readily get our hands on. The point I was trying to make in my original comment was that although power law distributions seem to be a popular topic of conversation for the past few years, they aren't exactly a new discovery. Given that wealth and income follow a Pareto distribution, perhaps it isn't that surprising that VC returns do too.
Pareto power laws can't be stepwise, the point I was trying to make is that 80/20 distribution can be, and they are related to but not necessarily the same as power laws.
Hi! I'm not a site administrator, so I don't know why you were hellbanned. I read your comments history list to see if I could found a cause (for example an extremely offensive comment, or spam) but I couldn't find anything annoying. []
I saw that a lot of your comments are oneliners. In this community we generally don't like them and they can get you a downvote. Try to expand them and add more details. This information may be useful for the other members and it's more probable to get a few upvotes.
For example: http://news.ycombinator.com/item?id=4161475
Says: "Bookmarked ..."
A better comment could be for example: (It depends a lot on your background.) "I work as a web designer. We have a giant banner with the html symbols at the office, but it's a pain in the back to find the correct one. We were tried to make short versions with the most used symbols but that wasn't useful. I will bookmark this right now."
Or sometimes it is good enough to upvote to the history (without any comment).
[]There are (probably) other reasons for hellbanning that can't be found reading the comments, for example massive sockpuppets.
- What the hell can be so complicated about "explaining an acne medication to a patient"? It can't be hard to use. Is it the risks associated? How to respond to numerous reactions and side effects?
- Why did it take a dermatologist (which would put her in the ~90th percentile of intelligence) so long to realize she was repeating the same thing over and over and over, and that this could therefore be automated?
- If a video -- not interactive tutorial -- fully replaces everything her in-person explanation provides, then she must not have been getting questions from patients, which makes me wonder how much of it they were actually following and was informative to them.
IANAL & IANAD, but I'd wager small sums of real money that there are tons of legal implications around a doctor explaining how to use a medicine vs handing it off to a machine or even a nurse or other medical practitioner. Think: "my doctor didn't properly explain how this medicine would interact with this other medicine and as a result I was harmed, now I feel that my doctor should be held liable." Were I a doctor, that would probably be the very first thought in my mind immediately following how to automate an otherwise time-consuming process.
There are also considerations about ease of access. To a technologically lay person, the perceived complication and costs around a professionally edited instructional video can seem insurmountable or not cost-effective.
Because most doctors are not focused on tech. There are probably a lot of smart things you could do that have nothing to do with tech that you just wouldn't think about.
The video doesn't replace everything. It covers the bases and then sometimes a small number of questions remain. She used to get a ton of interrupting questions - she knows the common questions and touches on all of them in the video. Sometimes one-off questions remain.
http://economix.blogs.nytimes.com/2013/01/02/why-49-is-a-mag...
[1] Barabási, Albert-László (2010). Bursts : the hidden pattern behind everything we do. New York N.Y.: Dutton.
an alternative explanation to the best funds being good at finding winners is that they are good at avoiding the investments that have a low chance of being homeruns. this is where I was heading with my last paragraph but realized it requires a whole new post.
It may also be because they somehow help those startups succeed. Thus, they don't pick winners, they make winners.
Another possibility is that successful startup founders self select themselver into those founds.
This is just as true in investing-people tend to espouse either "all skill" (e.g. Warren Buffett") or "all luck" (one common interpretation of the Efficient Market Hypothesis.) Even defining skill in investing is difficult. High-risk investments tend to have a high return, so skill is getting an outsized return compared to the amount of risk involved. But the simple measures of risk (e.g. Beta) are not good actual measure of risk. For example, a company whose stock price suddenly plummeted is often a good investment since the market tends to overreact to bad news. Furthermore, the stock is now lower-risk because it has less to lose. But it will appear extremely high risk by most common measures.
I think it's a decent assumption in VC to treat all investments at stage X as equally risky. E.g. angel investments are one category, series A as another. This is obviously not 100% perfect but is a decent approximation.
Then we can ask the following question: how did Sequoia Capital's series A investments in a certain time period (say 2000-2005) perform compared to all other series A investments? It's important that you look at all of a VC's investments and not just a particular fund, because firms will often bury their bad funds.
I have no idea if that kind of data is available anywhere, though.